eADMET GmbH develops and markets innovative IT solutions for the prediction of important properties of chemicals and drugs, especially physical and ("drug-like") characteristics. The term "eADMET" stands for "early&electronic ADMET" - computational models designed to predict the ADMET (absorption, distribution, metabolism, excretion and toxicity) of molecules.
We are an enterprise solution provider committed to long-term partnerships with our customers. For the full range of small to large business organizations, we offer business consulting and IT infrastructure solutions that enable our clients to exploit the potential of an up-to date in-silico property prediction infrastructure with minimum effort.
The central product of eADMET is OCHEM, a web-based database system that links the molecular structures of chemical substances to their physical and ADME / Tox characteristics. Based on a comprehensive data collection and excellent algorithms, the properties of new substances can be estimated accurately. Chemoinformaticians in from all over the world constantly add new information to the publicly accessible version, which are then associated with current, publicly available data and the specific expertise of eADMET.
Our development efforts are focussed on the identification of reliable predictions. Our technology allows to quickly develop high quality prediction models. eADMET thus contributes to realizing the full potential of computer technology in the chemical industry. We make it easy to avoid misinterpretations of model results.
The high accuracy of our method was confirmed in multiple published studies with large pharmaceutical companies. We have developed special software solutions for our industrial customers that allow quick adaptation to individual requirements.
Our products are based on Oracle database solutions as well as Oracle technology and tools. As a Oracle Gold Partner we are able to access the entire Oracle technology and product portfolio and can tailor an optimal solution for your enterprise taking the full range of Oracle applications as well as server and storage offerings into account.
eADMET is supported by funds from the GO-Bio-Phase II program and has closed a seed-funding with the High-Tech Start-Up Fund (HTGF) and Bavaria capital. GO-Bio is a funding program by the Federal Ministry for Education and Research (BMBF) and is coordinated by the project executing organization Jülich.

More about eADMET
  • News

    Ascenion coaches spin-off from the Helmholtz Zentrum München

    The Helmholtz Zentrum München and its technology transfer partner Ascenion helped get a new start-up off the ground: eADMET GmbH. The chemoinformatics company develops and commercializes new IT solutions for the prediction of physical and ADME/Tox (‘drug-like’) properties of new potential m ... more